University of Michigan Receives First Place from AMCP Foundation in 2022 National P&T Competition
Alexandria, Va., April 13, 2022 — AMCP Foundation and its partners announced the top schools of pharmacy in its 22nd Annual National Student Pharmacist P&T Competition at the conclusion of AMCP 2022. The competition convened student pharmacists from around the country to develop a formulary drug monograph, considering evidence gaps; value; health equity; and utilization management tools.
The 2022 recipients are:
- First Place: University of Michigan College of Pharmacy
- Second Place: Rutgers, the State University of New Jersey Ernest Mario School of Pharmacy
- Third Place: University of Washington School of Pharmacy
- National Finalists: University of Minnesota College of Pharmacy and University of Southern California School of Pharmacy
Designed to provide a firsthand experience in the complex practice of managing a formulary, the P&T Competition had more than 60 PharmD programs nationwide participate. Fifteen teams were recognized as semifinalists, and five teams were subsequently national finalists and presented to a mock P&T Committee.
“The exceptional submissions we received from students across the country is a great indicator of a secure and innovative future for managed care pharmacy,” said Paula J. Eichenbrenner, MBA, CAE, AMCP Foundation executive director. “AMCP Foundation congratulates all of this year’s participants and looks forward to the start of their successful careers in our industry.”
The teams of four worked through a series of assignments using a product dossier in the AMCP Format for Formulary Submissions. The study drug for the 2022 P&T Competition was PONVORY® (ponesimod) once-daily tablets. Ponvory is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Genentech, a member of the Roche Group, is the Executive Sponsor of the National Student Pharmacist P&T Competition. AMCP Foundation thanks Genentech for its generous support of pharmacists and the managed care pharmacy profession.
Supernus Pharmaceuticals, Inc. is a supporting sponsor for the National Student Pharmacist P&T Competition. AMCP Foundation thanks Janssen Pharmaceuticals, Inc., for use of the Ponvory dossier; FormularyDecisions for hosting AMCP eDossiers; and all advisors, faculty and local AMCP members for who mentor the next generation.
Learn more about partnering with AMCP Foundation to develop managed care leaders.
About AMCP
AMCP is the professional association leading the way to help patients get the medications they need at a cost they can afford. AMCP’s diverse membership of pharmacists, physicians, nurses, biopharmaceutical professionals, and other stakeholders leverage their specialized expertise in clinical evidence and economics to optimize medication benefit design and population health management and help patients access cost-effective and safe medications and other drug therapies. AMCP members improve the lives of nearly 300 million Americans served by private and public health plans, pharmacy benefit management firms, and emerging care models. Visit www.amcp.org.
About AMCP Foundation
Established in 1990, the 501(c)3 nonprofit AMCP Foundation is the philanthropic arm of the Academy of Managed Care Pharmacy (AMCP). It exists to advance collective knowledge and insights on major issues associated with the practice of pharmacy in managed care health care settings. By facilitating innovative research initiatives and providing educational opportunities to learn about managed care pharmacy, the AMCP Foundation invests in the future of managed care. Visit www.amcpfoundation.org.
Featured News & Resources
See Full CalendarHBCU Travel Awards for AMCP25
Mid-South AMCP Day of Education 2025
Southwest AMCP Annual Day of Education 2025
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.